<p>SL4-MUC1 cells (1×10<sup>6</sup> cells/50 µL) were injected into the space under the cecal serosa of B6 mice or MUC1.Tg mice. Ten days after injection, mice were sacrificed, the cecal tumors, spleens, and MLNs were resected and single cell suspensions were prepared. (A) Cells from MUC1.Tg mice in each organ were stained with CD4, Foxp3, and Ki-67 and percentage of Ki-67<sup>+</sup> Treg cells in each organ were shown. Lines indicate the median values. (B) Cells from tumor tissues in B6 or MUC1.Tg mice were stained with CD4, Foxp3, and Ki-67 and the absolute number of Ki-67<sup>+</sup> Treg cells was calculated. The absolute number of Ki-67<sup>+</sup> Treg cells normalized to the cecal weight was illustrated. A representative result from...
<p>(a), Splenocytes were stained with FITC-CD4 and PE-FoxP3 antibody, the frequencies of Treg cells ...
<p>Lymphocytes were isolated from the spleens, irrelevant lymph nodes, tumor draining lymph nodes, a...
<p>Respectively on day 1, 3, 5, 7, 9 after treatment initiation in the independent treatment groups,...
<p>SL4-MUC1 cells (1×10<sup>6</sup> cells/50 µL) were injected into the space under the cecal serosa...
<p>Single cell suspension from spleen, tumor draining lymph nodes, and tumor of control and MIP trea...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, were treated as ind...
<p>Cells were isolated from spleen and MLN on day 7, 14, 21, and 35 following DSS treatment and dete...
MUC1 transgenic (MUC1.Tg) mice have widely been used as model recipients of cancer immunotherapy wit...
MUC1 transgenic (MUC1.Tg) mice have widely been used as model recipients of cancer immunotherapy wit...
<p>(<b>a</b>) Dot plots show the number of peripheral blood Tregs in PBS (i–iv) or JBS (v-,viii) fed...
<p>Antigen specificity of Treg cell suppression was investigated <i>in vitro</i>. (A) MUC1-specific ...
<p>(A-D) Mice were treated with 0.1 mg 1D11 or mouse IgG1 (i.p., 3×week), starting at day 1 of tumor...
<p>A: Spleens from CT26 tumor-bearing mice, treated with PBS or BLM, were harvested and the cells we...
<p>SL4-mock cells or SL4-MUC1 cells (1×10<sup>6</sup> cells/50 µL) were injected into the space unde...
<p>MC38 colon tumor cells (2×10<sup>6</sup>) were implanted subcutaneously into female C57BL/6 mice....
<p>(a), Splenocytes were stained with FITC-CD4 and PE-FoxP3 antibody, the frequencies of Treg cells ...
<p>Lymphocytes were isolated from the spleens, irrelevant lymph nodes, tumor draining lymph nodes, a...
<p>Respectively on day 1, 3, 5, 7, 9 after treatment initiation in the independent treatment groups,...
<p>SL4-MUC1 cells (1×10<sup>6</sup> cells/50 µL) were injected into the space under the cecal serosa...
<p>Single cell suspension from spleen, tumor draining lymph nodes, and tumor of control and MIP trea...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, were treated as ind...
<p>Cells were isolated from spleen and MLN on day 7, 14, 21, and 35 following DSS treatment and dete...
MUC1 transgenic (MUC1.Tg) mice have widely been used as model recipients of cancer immunotherapy wit...
MUC1 transgenic (MUC1.Tg) mice have widely been used as model recipients of cancer immunotherapy wit...
<p>(<b>a</b>) Dot plots show the number of peripheral blood Tregs in PBS (i–iv) or JBS (v-,viii) fed...
<p>Antigen specificity of Treg cell suppression was investigated <i>in vitro</i>. (A) MUC1-specific ...
<p>(A-D) Mice were treated with 0.1 mg 1D11 or mouse IgG1 (i.p., 3×week), starting at day 1 of tumor...
<p>A: Spleens from CT26 tumor-bearing mice, treated with PBS or BLM, were harvested and the cells we...
<p>SL4-mock cells or SL4-MUC1 cells (1×10<sup>6</sup> cells/50 µL) were injected into the space unde...
<p>MC38 colon tumor cells (2×10<sup>6</sup>) were implanted subcutaneously into female C57BL/6 mice....
<p>(a), Splenocytes were stained with FITC-CD4 and PE-FoxP3 antibody, the frequencies of Treg cells ...
<p>Lymphocytes were isolated from the spleens, irrelevant lymph nodes, tumor draining lymph nodes, a...
<p>Respectively on day 1, 3, 5, 7, 9 after treatment initiation in the independent treatment groups,...